June 15, 2018
In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Winston & Strawn
- Kessler Topaz
- Gustafson Gluek
- Kirkland & Ellis
- Morgan Lewis
- Smith Segura Raphael & Leger
- DLA Piper
- Durrette Arkema
- Zelle LLP
- Garwin Gerstein
- Girard Sharp
- Wilson Sonsini
- White & Case
- Lockridge Grindal
- Grabar Law
- O'Hagan Meyer
- Ventker Henderson
- Joseph Saveri Law Firm
- Kaufman & Canoles
- DurretteCrump
- Duncan & Allen
- Fisher & Phillips
- Faruqi & Faruqi
- Wexler Boley
- Motley Rice
- Glasser & Glasser
- McGuireWoods
- Woods Rogers
- Hagens Berman
- Marcus & Shapira
- Boies Schiller
- Williams & Connolly
- Willcox & Savage
- BoiesBattin
- The Office of Craig C. Reilly
- Gibson Dunn
- Nussbaum Law Group
- Katten Muchin
- Crenshaw Ware
- Crowell & Moring
- Hartley LLP
- Heins Mills
- Furniss Davis
- Hangley Aronchick
- Taus Cebulash
- Goldman Ismail
- Radice Law Firm
- Cohen Milstein
- Sperling Kenny
- Miller Shah
- Wolcott Rivers
- Berger Montague
- Glancy Prongay
- Labaton Keller
Companies
- Albertsons Cos. Inc.
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Merck & Co. Inc.
- McKesson Corp.
- Fraternal Order of Police
- Humana Inc.
- Giant Eagle Inc.
- CVS Health Corp.
- Health Net Inc.
- H.D. Smith LLC
- Cencora Inc.
- Glenmark Pharmaceuticals Ltd.
- Mutual Drug
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- United Food & Commercial Workers International Union
- Cardinal Health Inc.
- Zydus Pharmaceuticals Inc.
- Wegmans Food Markets Inc.
- Centene Corp.
- The Kroger Co.
- Rite Aid Corp.
- H‑E‑B LP
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 27, 2023
Merck Says It Paid $573M To Settle Zetia Antitrust Case
Pharmaceutical giant Merck & Co. Inc. paid $573 million to settle antitrust claims this month over allegations it conspired with Glenmark Pharmaceuticals to delay the launch of generic versions of the blockbuster cholesterol drug Zetia, according to first-quarter financial results released Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login